4//SEC Filing
PTC THERAPEUTICS, INC. 4
Accession 0001070081-17-000090
$PTCTCIK 0001070081operating
Filed
May 24, 8:00 PM ET
Accepted
May 25, 4:18 PM ET
Size
19.7 KB
Accession
0001070081-17-000090
Insider Transaction Report
Form 4
Rothera Mark
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2017-05-24$10.85/sh+2,000$21,700→ 33,739 total - Exercise/Conversion
Stock Option (Right To Buy)
2017-05-24−2,000→ 6,125 totalExercise: $10.85Exp: 2023-05-15→ Common Stock (2,000 underlying)
Holdings
- 69,227
Stock Option (Right To Buy)
Exercise: $10.85Exp: 2023-05-15→ Common Stock (69,227 underlying) - 69,550
Stock Option (Right To Buy)
Exercise: $51.00Exp: 2025-01-01→ Common Stock (69,550 underlying) - 56,000
Stock Option (Right To Buy)
Exercise: $11.23Exp: 2027-01-02→ Common Stock (56,000 underlying) - 9,216(indirect: By Trust)
Common Stock
- 65,000
Stock Option (Right To Buy)
Exercise: $27.05Exp: 2024-01-27→ Common Stock (65,000 underlying) - 70,000
Stock Option (Right To Buy)
Exercise: $30.86Exp: 2026-01-03→ Common Stock (70,000 underlying)
Footnotes (7)
- [F1]This transaction involved a bona fide gift of securities by the reporting person to a trust of which the reporting person's spouse is a beneficiary.
- [F2]This option was granted on May 15, 2013 and vests as follows: 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on January 31, 2014.
- [F3]This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter beginning on June 15, 2014.
- [F4]This option was granted on January 28, 2014, and vests over four years, with 25% of the shares underlying the option vested on January 1, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
- [F5]This option was granted on January 2, 2015, and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.
- [F6]This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
- [F7]This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.
Issuer
PTC THERAPEUTICS, INC.
CIK 0001070081
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070081
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 4:18 PM ET
- Size
- 19.7 KB